Literature DB >> 2401893

Lip-length and snout indices: methods for quantitative assessment of peri-oral facial muscle strength.

C Jansen1, F G Jennekens, J H Wokke, G J Leppink, H J Wijnne.   

Abstract

Two simple bedside methods for the assessment of perioral muscle function are described. Using a marking gauge, the width of the mouth can be measured easily and accurately. Lip-length (LL) and snout (S) indices are expressions of the degree to which the width of the mouth can be lengthened or shortened. Facial muscle weakness as present in patients with various neuromuscular diseases results in low values for both indices. LL- and S-indices are measured by 3 observers in 19 healthy volunteers. Interobserver variation is negligible for the LL-index and large for the S-index. Intraobserver variation is moderate for both indices but slightly smaller for the LL- than for the S-index. The LL-index is suited for the assessment of changes in peri-oral musculature in longitudinal investigations.

Entities:  

Mesh:

Year:  1990        PMID: 2401893     DOI: 10.1016/0022-510x(90)90212-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Physical Therapy for Iatrogenic Facial Paralysis: A Systematic Review.

Authors:  Nneoma S Wamkpah; Latoya Jeanpierre; Judith E C Lieu; Drew Del Toro; Laura E Simon; John J Chi
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-09-24       Impact factor: 6.223

2.  Acupuncture for sequelae of Bell's palsy: a randomized controlled trial protocol.

Authors:  Hyo-Jung Kwon; Jong-In Kim; Myeong Soo Lee; Jun-Yong Choi; Sungkeel Kang; Jie-Yoon Chung; Young-Jin Kim; Seung-Hoon Lee; Sanghoon Lee; Dongwoo Nam; Yong-Suk Kim; Jae-Dong Lee; Do-Young Choi
Journal:  Trials       Date:  2011-03-09       Impact factor: 2.279

3.  Acupuncture for the sequelae of Bell's palsy: a randomized controlled trial.

Authors:  Hyo-Jung Kwon; Jun-Yong Choi; Myeong Soo Lee; Yong-Suk Kim; Byung-Cheul Shin; Jong-In Kim
Journal:  Trials       Date:  2015-06-03       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.